Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients.
Troost JP, Gipson DS, Carlozzi NE, Reeve BB, Nachman PH, Gbadegesin R, Wang J, Modersitzki F, Massengill S, Mahan JD, Liu Y, Trachtman H, Herreshoff EG, DeWalt DA, Selewski DT. Troost JP, et al. Among authors: gipson ds. Health Psychol. 2019 May;38(5):410-421. doi: 10.1037/hea0000679. Health Psychol. 2019. PMID: 31045424 Free PMC article.
The clinical trial imperative.
Gipson D, Trachtman H. Gipson D, et al. Pediatr Nephrol. 2005 Jan;20(1):5-9. doi: 10.1007/s00467-004-1681-z. Epub 2004 Nov 25. Pediatr Nephrol. 2005. PMID: 15602662 Review.
Differential risk of remission and ESRD in childhood FSGS.
Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB. Gipson DS, et al. Pediatr Nephrol. 2006 Mar;21(3):344-9. doi: 10.1007/s00467-005-2097-0. Epub 2006 Jan 5. Pediatr Nephrol. 2006. PMID: 16395603
Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group.
Joy MS, Gipson DS, Dike M, Powell L, Thompson A, Vento S, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H. Joy MS, et al. Among authors: gipson ds. Clin J Am Soc Nephrol. 2009 Jan;4(1):39-47. doi: 10.2215/CJN.02310508. Epub 2008 Dec 10. Clin J Am Soc Nephrol. 2009. PMID: 19073787 Free PMC article. Clinical Trial.
Renal manifestations of systemic illness in children.
Gibson KL, Gipson DS, Massengill SF. Gibson KL, et al. Among authors: gipson ds. Semin Nephrol. 2009 Jul;29(4):360-9. doi: 10.1016/j.semnephrol.2009.03.012. Semin Nephrol. 2009. PMID: 19615557 Review.
Management of childhood onset nephrotic syndrome.
Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA. Gipson DS, et al. Pediatrics. 2009 Aug;124(2):747-57. doi: 10.1542/peds.2008-1559. Epub 2009 Jul 27. Pediatrics. 2009. PMID: 19651590
Management patterns of childhood-onset nephrotic syndrome.
MacHardy N, Miles PV, Massengill SF, Smoyer WE, Mahan JD, Greenbaum L, Massie S, Yao L, Nagaraj S, Lin JJ, Wigfall D, Trachtman H, Hu Y, Gipson DS. MacHardy N, et al. Among authors: gipson ds. Pediatr Nephrol. 2009 Nov;24(11):2193-201. doi: 10.1007/s00467-009-1282-y. Epub 2009 Aug 12. Pediatr Nephrol. 2009. PMID: 19672630
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group.
Joy MS, Gipson DS, Powell L, MacHardy J, Jennette JC, Vento S, Pan C, Savin V, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H. Joy MS, et al. Among authors: gipson ds. Am J Kidney Dis. 2010 Jan;55(1):50-60. doi: 10.1053/j.ajkd.2009.08.019. Epub 2009 Nov 22. Am J Kidney Dis. 2010. PMID: 19932542 Free PMC article. Clinical Trial.
228 results